Detailed information
| LncRNA Name | SOX2OT |
| Variant Type | copy number variation |
| Variant ID | 3q26.3 |
| Species | human |
| Circulating | ✕ |
| Survival | ✕ |
| CeRNA | ✕ |
| Methylation | ✕ |
| Enhancer | ✕ |
| Drug | ✕ |
| Disease/Trait | lung squamous cell carcinoma |
| LncRNA Target Gene | NA |
| Tissue | LSCC tissues |
| Experiment | qPCR etc. |
| Function Description | In conclusion, eight out of the nine tested genes were recurrently over-expressed, but SOX2 and SOX2OT were the most consistently highly over-expressed and thus are the best candidates to be driver genes of 3q26.3 amplifications. |
| Pubmed ID | 20126410 |
| Year | 2010 |
| Title | SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. |
| External Links | |
|---|---|
| Links For SOX2OT | GeneCards HGNC NONCODE LncRNAWiki lncrnadb |
| Links For lung squamous cell carcinoma | OMIM Cosmic |
| Links For 3q26.3 | dbSNP ClinVar OMIM |